A Study of LY3337641 in Rheumatoid Arthritis

NCT02628028 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

286

Enrollment

INDUSTRY

Sponsor class

Stopped The trial was terminated after an interim analysis of efficacy and safety data did not warrant continuation of the trial.

Conditions

Rheumatoid Arthritis

Interventions

DRUG: LY3337641
DRUG: Placebo

Sponsor

Eli Lilly and Company